Navion Neurosciences
Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.
Navion Neurosciences raised $10.8M in a Seed round announced September 9, 2026, according to biospace.com. Investors in that round: Angelini Lumira Biosciences Fund, 3B Future Health Fund, UVA Licensing & Ventures Group, Virginia Innovation Partnership Corporation, Virginia Tech Carilion (VTC) Innovation Fund.
Founders and team
- AKAndrew Krouse Foundersource: crunchbase.com
- MPManoj Patel Foundersource: crunchbase.com
- MHMichelle Higgin Foundersource: crunchbase.com
- TRTom Richardson Foundersource: crunchbase.com
- AJAndrew J. Krouse President and Chief Executive Officersource: crunchbase.com
- GBGerry Brunk Board membersource: crunchbase.com
- MBMarianne Bjordal Board membersource: crunchbase.com
- MIMichael Innes CBOsource: crunchbase.com
Raise history
- Seed · $10.8MAAngelini Lumira Biosciences Fund (lead),
33B Future Health Fund, UUVA Licensing & Ventures Group,
VVirginia Innovation Partnership Corporation,
VVirginia Tech Carilion (VTC) Innovation Fund
Source: biospace.com
Investors
33B Future Health Fund
- AAngelini Lumira Biosciences Fund
- KKids Connect Charitable Fund
- UUVA Licensing & Ventures Group
VVirginia Innovation Partnership Corporation
VVirginia Tech Carilion (VTC) Innovation Fund
Related ai companies
GGood Tape$600K · Oct 2, 2026
OOptimizeGEO.ai$80M · Oct 1, 2026
11club AI$2.2M · Oct 1, 2026
PPredictive AIOct 1, 2026
JJAOPS$260M · Oct 1, 2026
EestaieOct 1, 2026
OOpensOct 1, 2026
KKeepsake Family HistoryOct 1, 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/navion-neurosciences.